patented technology to grow and expand adult Stem Cells
Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Fast Facts

Name Symbol Exchange
Pluristem Life Systems, Inc. PSTI NAZ
Shares Outstanding Financials Industry
26.32M View Filings Technology & Medical
Transfer Agent   Website
Nevada Agency & Trust Company   http://www.pluristem.com
Last changed at 07-Feb-2011 02:43PM by emit

Top Rated Messages

Sorry, no rated messages found

AGORACOM Quick Tips

Start A New HUB. Control. Quality. Refreshing. ... Start One Now
Watch
Today's Show
in 00:00:000

President's D.D.

4-17-12, Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial for the treatment of peripheral artery disease (PAD). read more

Stock Quote

Hub Leaders